TNF Blocking Therapies and Immunomonitoring in Patients with Inflammatory Bowel Disease

Since their appearance in the armamentarium for inflammatory bowel disease (IBD) more than a decade ago, antitumor necrosis factor (TNF) inhibitors have demonstrated beneficial activity in induction and maintenance of clinical remission, mucosal healing, improvement in quality of life, and reduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Altwegg, Romain, Vincent, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976924/
https://www.ncbi.nlm.nih.gov/pubmed/24757282
http://dx.doi.org/10.1155/2014/172821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976924/
https://www.ncbi.nlm.nih.gov/pubmed/24757282
http://dx.doi.org/10.1155/2014/172821

Ejemplares similares